Hepion Pharmaceuticals, Inc. announced the appointment of Todd M. Hobbs, M.D., to the newly created position of Chief Medical Officer (“CMO”), effective February 16, 2021. In this role, Dr. Hobbs will help lead Hepion’s engagement with the U.S. Food and Drug Administration (“FDA”), global and national thought leaders, key policymakers, and professional associations.